SubQ Drug Squad Adds Gilead, Regeneron to Antitrust Safe Zone
Published Date: 6/13/2025
Notice
Summary
The Subcutaneous Drug Development & Delivery Consortium just added four new members, including big names like Gilead Sciences and Regeneron. This update keeps their special legal protections against antitrust lawsuits in place while they work together on drug research. If you’re involved or interested, watch for more membership updates coming soon—no big money changes yet, just teamwork growing stronger!
No Economic Impacts Identified for this Document
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in